Clearline Capital’s Pfizer PFE Stock Holding History

Clearline Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-31,620	Closed	-$981K	–	91
2020 Q2	$981K	Buy	+31,620	New	+$1.07M	0.32%	44
2018 Q1	–	Sell	-10,378	Closed	-$357K	–	56
2017 Q4	$357K	Buy	+10,378	New	+$354K	0.18%	45
2016 Q1	–	Sell	-206,195	Closed	-$6.32M	–	50
2015 Q4	$6.32M	Buy	+206,195	New	+$6.49M	0.98%	30
2014 Q3	–	Sell	-149,794	Closed	-$4.22M	–	78
2014 Q2	$4.22M	Buy	+149,794	New	+$4.27M	0.67%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clearline Capital's PFE Position: Q3 2020 in Review

Clearline Capital sold out of Pfizer (PFE) in Q3 2020, closing a stake of 31,620 shares — an estimated $981K sold.

Clearline Capital first reported a position in PFE in Q2 2014 and held it in 4 quarters. The position peaked at $6.32M in Q4 2015. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Clearline Capital reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
Clearline Capital sold 31,620 Pfizer shares in Q3 2020, an estimated $981K.
Clearline Capital first reported a position in Pfizer in Q2 2014 and held it in 4 quarters.
Clearline Capital's Pfizer position peaked at $6.32M in Q4 2015.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Clearline Capital's 13F filing for Q3 2020, filed 16 Nov 2020.